EUVIMEDEUVIMED entdecken
Open Access

Cardiomyopathy-associated variants alter the structure and function of the α-actinin-2 actin-binding domain

Alexandra E Atang, Robyn T Rebbeck, David D Thomas, Adam W Avery

Biochemical and Biophysical Research Communications · 2023

DOI: 10.1016/j.bbrc.2023.05.050 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2023. Verfasst von Alexandra E Atang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Oakland University, Rochester, MI, 48309-4479, USA. Hauptthemen laut MEDLINE: Cardiomyopathies, Cardiomyopathy, Dilated, Cardiomyopathy, Hypertrophic. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, Oakland University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hypertrophic cardiomyopathy (HCM), dilated cardiomyopathy (DCM), and restrictive cardiomyopathy (RCM) are characterized by thickening, thinning, or stiffening, respectively, of the ventricular myocardium, resulting in diastolic or systolic dysfunction that can lead to heart failure and sudden cardiac death. Recently, variants in the ACTN2 gene, encoding the protein α-actinin-2, have been reported in HCM, DCM, and RCM patients. However, functional data supporting the pathogenicity of these variants is limited, and potential mechanisms by which these variants cause disease are largely unexplored. Currently, NIH ClinVar lists 34 ACTN2 missense variants, identified in cardiomyopathy patients, which we predict are likely to disrupt actin binding, based on their localization to specific substructures in the α-actinin-2 actin binding domain (ABD). We investigated the molecular consequences of three ABD localized, HCM-associated variants: A119T, M228T and T247 M. Using circular dichroism, we demonstrate that the mutant ABD proteins can attain a well-folded state. However, thermal denaturation studies show that all three mutations are destabilizing, suggesting a structural disruption. Importantly, A119T decreased actin binding, and M228T and T247M cause increased actin binding. We suggest that altered actin binding underlies pathogenesis for cardiomyopathy mutations localizing to the ABD of α-actinin-2.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CardiomyopathiesCardiomyopathy, DilatedCardiomyopathy, HypertrophicHumansActininActinsMutation

Stichwörter der Autor:innen

Actin bindingCircular dichroismProtein foldingThermal denaturation

Substanzen

ActininActinsACTN2 protein, human

Autor:innen und Institutionen

  • Department of Chemistry, Oakland University, Rochester, MI, 48309-4479, USA.
  • Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, 55455, USA.
  • Department of Chemistry, Oakland University, Rochester, MI, 48309-4479, USA. Electronic address: awavery@oakland.edu.

Förderung

  • NHLBI NIH HHS
  • Oakland University

Zitieren

APA

Atang, A. E., Rebbeck, R. T., Thomas, D. D., & Avery, A. W. (2023). Cardiomyopathy-associated variants alter the structure and function of the α-actinin-2 actin-binding domain. Biochemical and Biophysical Research Communications. https://doi.org/10.1016/j.bbrc.2023.05.050

Vancouver

Atang AE, Rebbeck RT, Thomas DD, Avery AW. Cardiomyopathy-associated variants alter the structure and function of the α-actinin-2 actin-binding domain. Biochemical and Biophysical Research Communications. 2023. doi:10.1016/j.bbrc.2023.05.050

BibTeX
@article{Atang2023,
  author = {Atang, Alexandra E and Rebbeck, Robyn T and Thomas, David D and Avery, Adam W},
  title = {Cardiomyopathy-associated variants alter the structure and function of the α-actinin-2 actin-binding domain},
  journal = {Biochemical and Biophysical Research Communications},
  year = {2023},
  doi = {10.1016/j.bbrc.2023.05.050}
}
Kostenlos starten →